Detalhe da pesquisa
1.
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).
Invest New Drugs
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38842657
2.
[Ramucirumab Treatment for Unresectable Advanced Hepatocellular Carcinoma-A Review of Clinical Trial Data and Real-World Evidence in Japan].
Gan To Kagaku Ryoho
; 50(7): 799-807, 2023 Jul.
Artigo
em Japonês
| MEDLINE | ID: mdl-37496225
3.
Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma.
Oncology
; 100(1): 12-21, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731863
4.
Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study.
Nutr Cancer
; 74(9): 3118-3127, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285364
5.
Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis.
BMC Gastroenterol
; 21(1): 224, 2021 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34006250
6.
The relationship between oral-origin bacteria in the fecal microbiome and albumin-bilirubin grade in patients with hepatitis C.
J Gastroenterol Hepatol
; 36(3): 790-799, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744764
7.
Factors associated with bleeding after endoscopic variceal ligation in children.
Pediatr Int
; 63(10): 1223-1229, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464654
8.
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Gut
; 69(8): 1492-1501, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31801872
9.
Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.
Oncology
; 98(9): 621-629, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32434180
10.
Serum Nutritional Markers as Prognostic Factors for Hepatic and Extrahepatic Carcinogenesis in Japanese Patients with Nonalcoholic Fatty Liver Disease.
Nutr Cancer
; 72(5): 884-891, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433263
11.
Rapid increase of platelet counts during antiviral therapy in patients with hepatitis C virus infection.
Hepatol Res
; 50(1): 47-56, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31496023
12.
Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma.
Hepatol Res
; 50(3): 374-381, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721363
13.
The Prevalence of Mixed Hepatitis C Virus Genotype Infection and Its Effect on the Response to Direct-Acting Antivirals Therapy.
Intervirology
; 62(1): 23-29, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207601
14.
Clinical characteristics and outcomes of candidates for second-line therapy, including regorafenib and ramucirumab, for advanced hepatocellular carcinoma after sorafenib treatment.
Hepatol Res
; 49(9): 1054-1065, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31033165
15.
Complete response by vitamin K2 analog monotherapy in sorafenib-failure advanced hepatocellular carcinoma: A case report.
Hepatol Res
; 49(3): 360-364, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30051950
16.
Spleen stiffness by 2-D shear wave elastography is the most accurate predictor of high-risk esophagogastric varices in children with biliary atresia.
Hepatol Res
; 49(10): 1162-1168, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132304
17.
Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.
J Gastroenterol Hepatol
; 34(1): 207-214, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30144360
18.
Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice.
Dig Dis Sci
; 64(9): 2581-2590, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30825110
19.
Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy.
J Viral Hepat
; 25(12): 1446-1451, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29993164
20.
Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93.
J Med Virol
; 90(4): 736-744, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29111616